NGEN
NGEN clinical trials: NERVGEN PHARMA CORP.
Every trial on ClinicalTrials.gov where NERVGEN PHARMA CORP. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
NGEN on the catalyst calendar · NGEN registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jul 2027Sponsor estimate | NCT07799532A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord InjuryNervGen Pharma · Chronic Spinal Cord Injury | NGENLead | Phase 3 | Recruiting | Locked | Locked | Locked |
| Dec 31, 2025Actual | NCT05965700NVG-291 in Spinal Cord Injury SubjectsNervGen Pharma · Spinal Cord Injuries | NGENLead | Phase 1/Phase 2 | Completed | Locked | Locked | Locked |
| Jun 4, 2023Actual | NCT05308953A Phase I Safety Study of NVG-291 in Healthy AdultsNervGen Pharma · Spinal Cord Injury | NGENLead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Jul 2027Sponsor estimatePhase 3NCT07799532A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord InjuryNervGen Pharma · Chronic Spinal Cord InjuryRecruitingNGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2025ActualPhase 1/Phase 2NCT05965700NVG-291 in Spinal Cord Injury SubjectsNervGen Pharma · Spinal Cord InjuriesCompletedNGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 4, 2023ActualPhase 1NCT05308953A Phase I Safety Study of NVG-291 in Healthy AdultsNervGen Pharma · Spinal Cord InjuryCompletedNGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner